NCT07193407 INOPASE - Performance and Safety Study of a Personalised SNM System
| NCT ID | NCT07193407 |
| Status | Recruiting |
| Phase | — |
| Sponsor | INOPASE Pty Ltd |
| Condition | Overactive Bladder (OAB) |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2026-02-27 |
| Primary Completion | 2026-03-02 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The goal of this clinical trial is to learn whether a new sacral neuromodulation (SNM) system (INO-SNM-01) can safely and effectively sense bladder nerve activity and provide stimulation to help manage symptoms of refractory overactive bladder in adult women aged 18-70 who have not responded to standard treatments. The main questions it aims to answer are: * Is there a clear relationship between bladder nerve activity and patient-reported urgency sensations? * Can targeted stimulation based on bladder nerve activity reduce overactive bladder symptoms? * Is the INO-SNM-01 System safe to use? Researchers will not use a comparison group in this study. Instead, all participants will receive the investigational device to see if it works as intended. Participants will undergo surgery to have a temporary trial lead implanted near the sacral nerve and spend up to 2 days in hospital for monitoring and testing to assess the device sensing and stimulation capabilities. Up to 10 participants will take part in this first-in-human feasibility study at a single site in Australia.
Eligibility Criteria
Inclusion Criteria: * Adult female participants between 18 and 70 years of age * Diagnosed with refractory overactive bladder that is resistant to behavioural therapy and/or pharmacotherapy, for at least 12 weeks * Experience at least 3 urgency episodes within a 24-hour period from the past 3 consecutive days (reported in a bladder diary) * Baseline of greater than 7 on the Overactive Bladder Symptom Score (OABSS) * Baseline score of greater than 12 on the International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS) * Willing to receive SNM therapy * Willing to provide free and Informed consent to participate in the clinical investigation * Able to understand all study instructions, willing to attend all study visits, and likely to comply with all study procedures Exclusion Criteria: * Participants who are diagnosed with stress urinary incontinence * Received tibial nerve stimulation therapy within the past 3 months * Received treatm